Abiopharma

SES AI Announces Inclusion in Russell 3000®Index

Kirby Corporation Announces Date for 2026 Second Quarter Earnings Release and Earnings Webcast

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

OTC Markets Group Welcomes Surge Energy Inc. to OTCQX

ADP to Announce Fourth Quarter Fiscal 2026 Financial Results on July 29, 2026

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Bitdeer Technologies Group Signs Colocation Lease Agreement for Tydal, Norway AI Data Center Site